Company Filing History:
1 out of 3,688 
1 out of 2,313 
1 out of 194 
Years Active: 1999-2005
Title: David R Borchelt: Innovator in Alzheimer's Disease Research
Introduction
David R Borchelt is a prominent inventor based in Baltimore, MD (US), known for his significant contributions to the field of Alzheimer's disease research. With a total of 4 patents, he has developed innovative diagnostic methods and transgenic models that advance our understanding of this complex condition.
Latest Patents
One of Borchelt's latest patents focuses on diagnostic methods for drug screening for Alzheimer's disease. This method employs tissue slices of mutant mouse hippocampal cells, which possess an extra copy of a mutant form of the presenilin-1 gene. The research indicates that these cells exhibit enhanced potentiation to tetanic stimuli. By testing candidate drugs on both wild-type and mutant hippocampal cells, a reduction in the enhanced potentiation of the mutant cells, without significant changes in the wild-type cells, suggests a successful candidate for treatment.
Another notable patent involves the development of transgenic mice expressing mutant human amyloid precursor protein (APP) that form congo red staining plaques. This transgenic non-human eukaryotic animal model demonstrates an age-related central nervous system disorder characterized by various symptoms, including agitation and seizures. The disorder's progression is directly related to brain levels of transgenic APP, highlighting the pathogenic activities of APP that are dissociated from amyloid formation.
Career Highlights
Throughout his career, David R Borchelt has worked with esteemed institutions, including The Johns Hopkins University. His research has significantly impacted the understanding of Alzheimer's disease and has paved the way for potential therapeutic interventions.
Collaborations
Borchelt has collaborated with notable colleagues in the field, including Sangram S Sisodia and Karen Hsiao. Their combined expertise has contributed to advancements in Alzheimer's research and the development of innovative solutions.
Conclusion
David R Borchelt's work in Alzheimer's disease research exemplifies the importance of innovation in addressing complex health challenges. His patents and research contributions continue to influence the scientific community and offer hope for future treatments.